Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 26, Status: Authorised
Checklist for the submission of Day 215 product information annexes for a post-opinion linguistic review (Word file)
Member states contact points for review of national versions of the content of mobile scanning and other technologies
Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages
Union Product Database (UPD) registration guide for UI and API users
Agenda - Clinical trials information system information day webinar
Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia
Human medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Date of authorisation: 14/02/1996, Revision: 43, Status: Authorised
Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Opsumit, macitentan, Date of authorisation: 20/12/2013, Revision: 28, Status: Authorised